PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.\', \'Covid Division, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.\', \'Department of Anesthesiology and Intensive Care, Sapienza University of Rome, Rome, Italy.\', \'Protect Medicine Division, Belcolle Hospital, Viterbo, Italy.\', \'Intensive Care Unit, Department of medical and Surgical Science and Traslational Medicine, Sant\'Andrea Hospital, Sapienza University of Rome, Rome, Italy.\', \'Microbiology Unit, Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.\', \'Virology Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.\', \'Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.\', \'COVID Unit - Medicine Division, Casilino Hospital, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.26925
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 33675235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all